Waters Users’ Meeting at ASMS 2013
Monday, May 13, 2013
Register for the Waters Users’ meeting at ASMS 2013 and learn about the latest developments in Mass Spectrometry from Waters experts as we reveal our new technologies and solutions.

Thermo Scientific at ASMS 2013
Monday, May 13, 2013
Learn how scientists and researchers are transforming science by applying innovative solutions to a wide range of qualitative and quantitative applications.

Mass. General, Duke Study Identifies Two Genes that Combine to Cause Rare Syndrome
Monday, May 13, 2013
Mutations in genes that regulate cellular metabolism found in families with ataxia, dementia and reproductive failure.

Selventa Strengthens Intellectual Property for SysDx™ Approach to Personalized Medicine
Thursday, May 09, 2013
Patent is core to Selventa’s SysDx™ approach to mining and comparing biological data for predicting a patient’s response or non-response to a drug.

Type 1 Diabetes and Heart Disease Linked by Inflammatory Protein
Wednesday, May 08, 2013
Therapeutic agents that block the protein calprotectin could potentially reverse or slow the progression of atherosclerosis in people with type 1 diabetes.

Succinate Levels Linked to Immune Response and Inflammation
Tuesday, May 07, 2013
Metabolic intermediate plays major role in alerting the immune system - measuring succinate levels may prove effective diagnostic tool in cancer.

Abide Therapeutics Announces Collaboration with Merck
Friday, May 03, 2013
Collaboration agreement to develop novel therapies for type 2 diabetes and metabolic diseases.

Merck and Pfizer Enter Worldwide Collaboration Agreement
Wednesday, May 01, 2013
Agreement to develop and commercialize ertugliflozin, an investigational medicine for type 2 diabetes.

<<	1 2 3 4 5 6 7	>>
Showing Results 1 - 10 of 1240